fmrfamide and Haemonchiasis

fmrfamide has been researched along with Haemonchiasis* in 1 studies

Other Studies

1 other study(ies) available for fmrfamide and Haemonchiasis

ArticleYear
Structural characterisation and pharmacology of KHEYLRFamide (AF2) and KSAYMRFamide (PF3/AF8) from Haemonchus contortus.
    Molecular and biochemical parasitology, 1999, May-25, Volume: 100, Issue:2

    The FMRFamide-related peptides (FaRPs), KHEYLRFamide (AF2) and KSAYMRFamide (PF3) were structurally characterised from the parasitic nematode of sheep, Haemonchus contortus (MH isolate). Both peptides were sequenced in a single gas-phase sequencing run and their structure confirmed by mass spectrometry which identified peptides of 920 Da (C-terminally amidated AF2) and 902/918 Da (C-terminally amidated non-oxidised/oxidised PF3, respectively). AF2 had inhibitory effects on H. contortus muscle and inhibited acetylcholine (ACh, 10 microM)-induced contractions, with a threshold for activity of 1 microM. PF3 induced concentration-dependent contractions of H. contortus (activity threshold, 10 nM) and enhanced ACh contractions. Compared with the MH isolate, an isolate of H. contortus which has reduced sensitivity to cholinergic drugs (Lawes isolate) was less sensitive to the effects of PF3. The concentration-response curves for the cholinergic compounds ACh and levamisole (LEV), and PF3, but not a control, KPNFIRFamide (PF4), showed a statistically similar shift. This study implicates PF3 in the modulation of cholinergic function in H. contortus.

    Topics: Amino Acid Sequence; Animals; Antinematodal Agents; FMRFamide; Haemonchiasis; Haemonchus; Levamisole; Mass Spectrometry; Molecular Sequence Data; Muscle Contraction; Neuropeptides; Sheep; Sheep Diseases

1999